Measuring oral direct inhibitors of thrombin and factor Xa: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis-Reference-Cited by-同舟云学术

Measuring oral direct inhibitors of thrombin and factor Xa: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis

Published:2013-04 Issue:4 Volume:11 Page:756-760
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Baglin T.¹,Hillarp A.²,Tripodi A.³,Elalamy I.⁴,Buller H.⁵,Ageno W.⁶

Affiliation:

1. Cambridge Haemophilia and Thrombophilia Centre; Addenbrookes Hospital; Cambridge University Hospitals NHS Trust; Cambridge UK

2. Department of Clinical Chemistry, University Hospital; University and Regional Laboratories Region Skane; Malmo Sweden

3. Angelo Bianchi Bonomi Hemophilia and Thrombosis Center; Department of Clinical Sciences and Community Health; Università degli Studi di Milano and IRCCS Cà Granda Maggiore Hospital Foundation; Milano Italy

4. Service Hematologie Biologie; Hopital Tenon; Paris France

5. Department of Vascular Medicine; Academic Medical Center; Amsterdam Netherlands

6. Department of Clinical and Experimental Medicine; University of Insubria; Varese Italy

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.12149/fullpdf

Reference16 articles.

1. Coagulation parameters in patients receiving dabigatran etexilate or rivaroxaban: two observational studies in patients undergoing total hip or total knee replacement;Freyburger;Thromb Res,2011

2. Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays;Lindahl;Thromb Haemost,2011

3. Dabigatran etexilate - a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity;van Ryn;Thromb Haemost,2010

4. In-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate;Wienen;Thromb Haemost,2007

5. Effects of the oral, direct factor Xa inhibitor rivaroxaban on platelet-induced thrombin generation and prothrombinase activity;Graff;J Clin Pharmacol,2007

Cited by 210 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Magnetic coagulometry: towards a new nanotechnological tool for ex vivo monitoring coagulation in human whole blood;Nanoscale;2024

2. Measuring and monitoring of hemostasis;Hemostasis Management of the Pediatric Surgical Patient;2024

3. Head-to-head ex vivo comparison of clinically used direct anticoagulant drugs;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-12-19

4. The efficacy and safety of direct factor Xa inhibitors versus vitamin K antagonists for atrial fibrillation in patients on hemodialysis: a meta-analysis of randomized controlled trials;Baylor University Medical Center Proceedings;2023-08-21

5. Pilot study on the probability of drug-drug interactions among direct oral anticoagulants (DOACs) and antiseizure medications (ASMs): a clinical perspective;Neurological Sciences;2023-08-07